$3250 | Single User
$4650 | Site License
$5650 | Global License

Pharmaceutical Outsourcing Services Market, By Service (Product design, Product testing, Consulting, Auditing and Assessment, Regulatory Affairs, Product maintenance, and Training), and Geography (NA, EU, APAC, and RoW) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated
[Lowest Price Guaranteed: $3,250]

Published by AnalystView: 01 Jul 2020 | 270565 | In Stock
Related Topics: Compliance , COVID , FDA , Pharmaceuticals , Training

Introduction

REPORT HIGHLIGHT

The pharmaceutical/biotechnology services outsourcing market is estimated to represent a global market of USD 50.8 billion by 2019 with growth rate of 7.8%.

Market Dynamics

Driving factors such as increasing approval of new therapeutics coupled with strategic mergers & acquisitions of key players to expand their presence in pharma & biotech industries are expected to remain on the top spot for the growth of pharmaceutical outsourcing services industry globally. For example, in December 2019, as per the article published by the Regulatory Affairs Professional Society, the number of new molecular entity published by the U.S. FDA (around 46) in 2019, was the highest compared to the new drugs approved till 2016.

On contrary, the drug development cost is increasing at a significant rate. According to the estimates of Pharmaceutical Research and Manufacturers of America (PhRMA), the total drug development related R&D spending in 2014 amounted to USD 51.2 billion. Thus, outsourcing process helps a company to save hefty amount, which is spent on R&D; hence, increasing demand for consulting services. On the flip side, raising issues on data security and growing concerns over third-party performance restrain the industry growth to some extent.

Service Takeaway

Service segment is bifurcated into Product design, Product testing, Consulting, Auditing and Assessment, Regulatory Affairs, Product maintenance, Training, and others. Of these, consulting service holds the highest share throughout the study period. In 2019, this segment has captured around 18.5% share and is likely to show robust growth during the forecast period. Consulting services such as remediation, quality management systems, and regulatory compliances are covered under this segment. On another side, regulatory affairs outsourcing is considered to grow with the highest growth rate over the forecast period. Associated benefits such as cost-effectiveness, reduce documentation, and pro-active risk management helps this segment to capture significant revenue share during the future period.

COVID-19 Impact and Recovery Analysis

The published research on pharmaceutical/biotechnology services outsourcing market provides a bird’s eye view of the current COVID-19 outbreak. Further, the study also considers the post-COVID-19 impact and offers a clear assessment of the projected industry fluctuations. The different factors that are likely to impact the overall market dynamics, including top performer segments, marginal growth segments and top loser segments and more are discussed in detail in this research report.


Regional Takeaway

In terms of region, developed regions such as North America and Europe accounted for the highest share. In 2019, these regions have captured over 75% revenue share collectively. However, Asia Pacific region is anticipated to show double-digit growth rates (11.2% from 2019-2021-2027) in during the future period. This region is considered to grow with the highest CAGR as it is well positioned to become a preferred destination for pharmaceutical studies. Furthermore, factors such as speedy recruitment, large patient pool, cost-effectiveness, and presence of high-quality infrastructure support the regional growth over the forecast period.

Key Vendor Takeaway

Companies such as Quantic Group, Parexel International, Lachman Associates, Concept Heidelberg, and GMP Pharmaceuticals are profiled in detail. Bolstered by a revival in the pharmaceutical industry, market profit of these players is expected to increase at a significant rate over the future period. Since the industry is fragmented in nature, with no one player accounting for significant revenue share, service-based competition is very high.

Key players are actively engaged in accelerating their pace of change by reducing service cost, focusing on core-competency, and reducing documentary burden. For instance, in July 2016, Quality context Ltd. collaborated with Clarity Compliance Solutions to offer computer system validation services to assure a specific process will consistently produce a product that meets quality attributes and predetermined specifications.

The market size and forecast for each segment has been provided for the period 2016 to 2027, considering 2019 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2021 to 2027 for every reported segment.

The years considered for the study are:

Historical Year – 2016 to 2018

Base Year – 2019

Estimated Year – 2020

Projected Year – 2027

The proposed reports analyse and evaluates the COVID-19 impact, and anticipated change on the future market scenario on this industry, by taking into the account the economic, political, technological, and social, parameters.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

MARKET, BY SERVICE

Product Design

Product Testing

Consulting

Auditing and Assessment

Regulatory Affairs

Product Maintenance

Training

Others

MARKET, BY REGION

North America

U.S.

Canada

Europe

Germany

France

Rest of Europe

Asia Pacific

India

China

Rest of APAC

Rest of the World

Middle East and Africa

Latin America

Table of Contents
for Pharmaceutical Outsourcing Services Market, By Service (Product design, Product testing, Consulting, Auditing and Assessment, Regulatory Affairs, Product maintenance, and Training), and Geography (NA, EU, APAC, and RoW) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated

  • TABLE OF CONTENT

    1. PHARMACEUTICAL OUTSOURCING SERVICES MARKET OVERVIEW

    1.1. Study Scope

    1.2. Assumption and Methodology

    2. EXECUTIVE SUMMARY

    2.1. Key Market Facts

    2.2. Geographical Scenario

    2.3. Companies in the Market

    3. PHARMACEUTICAL OUTSOURCING SERVICES KEY MARKET TRENDS

    3.1. Market Drivers

    3.1.1. Impact Analysis of Market Drivers

    3.2. Market Restraints

    3.2.1. Impact Analysis of Market Restraints

    3.3. Market Opportunities

    3.4. Market Future Trends

    4. PHARMACEUTICAL OUTSOURCING SERVICES INDUSTRY STUDY

    4.1. Porter’s Analysis

    4.2. Market Attractiveness Analysis

    4.3. Regulatory Framework Analysis

    4.4 PHARMACEUTICAL OUTSOURCING SERVICES MARKET: COVID-19 IMPACT ANALYSIS

    4.4.1 Pre-COVID-19 Impact Analysis

    4.4.2 Post-COVID-19 Impact Analysis

    4.4.3 Top Performing Segments

    4.4.4 Marginal Growth Segments

    4.4.5 Top Looser Segments

    4.4.6 Marginal Loss Segments

    5. PHARMACEUTICAL OUTSOURCING SERVICES MARKET LANDSCAPE

    5.1. Market Share Analysis

    6. PHARMACEUTICAL OUTSOURCING SERVICES MARKET – BY SERVICE

    6.1. Overview

    6.2. Product Design

    6.2.1. Overview

    6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    6.3. Product Testing

    6.3.1. Overview

    6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    6.4. Consulting

    6.4.1. Overview

    6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    6.5. Auditing and Assessment

    6.5.1. Overview

    6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    6.6. Regulatory Affairs

    6.6.1. Overview

    6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    6.7. Product Maintenance

    6.7.1. Overview

    6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    6.8. Training

    6.8.1. Overview

    6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    6.9. Others

    6.9.1. Overview

    6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    7. PHARMACEUTICAL OUTSOURCING SERVICES MARKET– BY GEOGRAPHY

    7.1. Introduction

    7.2. North America

    7.2.1. Overview

    7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    7.2.3. U.S.

    7.2.3.1. Overview

    7.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    7.2.4. Canada

    7.2.4.1. Overview

    7.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    7.3. Europe

    7.3.1. Overview

    7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    7.3.3. France

    7.3.3.1. Overview

    7.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    7.3.4. Germany

    7.3.4.1. Overview

    7.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    7.3.5. Rest of Europe

    7.3.5.1. Overview

    7.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    7.4. Asia Pacific (APAC)

    7.4.1. Overview

    7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    7.4.3. China

    7.4.3.1. Overview

    7.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    7.4.4. India

    7.4.4.1. Overview

    7.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    7.4.5. Rest of APAC

    7.4.5.1. Overview

    7.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    7.5. Rest of the World

    7.5.1. Overview

    7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    7.5.3. Latin America

    7.5.3.1. Overview

    7.5.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    7.5.4. Middle East and Africa

    7.5.4.1. Overview

    7.5.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    8. KEY VENDOR ANALYSIS

    8.1. Quantic Group

    8.1.1. Company Overview

    8.1.2. Product Benchmarking

    8.1.3. Key Developments

    8.2. Parexel International

    8.2.1. Company Overview

    8.2.2. Product Benchmarking

    8.2.3. Key Developments

    8.3. Lachman Associates

    8.3.1. Company Overview

    8.3.2. Product Benchmarking

    8.3.3. Key Developments

    8.4. Concept Heidelberg

    8.4.1. Company Overview

    8.4.2. Product Benchmarking

    8.4.3. Key Developments

    8.5. GMP Pharmaceuticals

    8.5.1. Company Overview

    8.5.2. Product Benchmarking

    8.5.3. Key Developments

    9. 360 DEGREE ANALYSTVIEW

    10. APPENDIX

    10.1. Research Methodology

    10.2. Abbreviations

    10.3. Disclaimer

    10.4. Contact Us

List Of Tables
in Pharmaceutical Outsourcing Services Market, By Service (Product design, Product testing, Consulting, Auditing and Assessment, Regulatory Affairs, Product maintenance, and Training), and Geography (NA, EU, APAC, and RoW) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated

List of Tables

Table 1 List of Acronyms

Table 2 Key Market Facts, 2016 – 2027

Table 3 Market Drivers: Impact Analysis

Table 4 Market Restraint: Impact Analysis

Table 5 Market Opportunity: Impact Analysis

Table 6 PEST Analysis

Table 7 Porter’s Five Forces Analysis

Table 8 Company Market Share Analysis

Table 9 Global Pharmaceutical Outsourcing Services Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Billion)

Table 10 Pharmaceutical Outsourcing Services Market, by Service, 2016 – 2027 (USD Billion)

Table 11 Pharmaceutical Outsourcing Services Market, by Geography, 2016 – 2027 (USD Billion)

Table 12 North America Pharmaceutical Outsourcing Services Market, 2016 – 2027 (USD Billion)

Table 13 U.S. Pharmaceutical Outsourcing Services Market, 2016 – 2027 (USD Billion)

Table 14 Canada Pharmaceutical Outsourcing Services Market, 2016 – 2027 (USD Billion)

Table 15 Europe Pharmaceutical Outsourcing Services Market, 2016 – 2027 (USD Billion)

Table 16 France Pharmaceutical Outsourcing Services Market, 2016 – 2027 (USD Billion)

Table 17 Germany Pharmaceutical Outsourcing Services Market, 2016 – 2027 (USD Billion)

Table 18 Asia Pacific Pharmaceutical Outsourcing Services Market, 2016 – 2027 (USD Billion)

Table 19 China Pharmaceutical Outsourcing Services Market, 2016 – 2027 (USD Billion)

Table 20 India Pharmaceutical Outsourcing Services Market, 2016 – 2027 (USD Billion)

Table 21 Latin America Pharmaceutical Outsourcing Services Market, 2016 – 2027 (USD Billion)

Table 22 MEA Pharmaceutical Outsourcing Services Market, 2016 – 2027 (USD Billion)

List Of Figures, Charts and Diagrams
in Pharmaceutical Outsourcing Services Market, By Service (Product design, Product testing, Consulting, Auditing and Assessment, Regulatory Affairs, Product maintenance, and Training), and Geography (NA, EU, APAC, and RoW) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated

List of Figures

Figure 1 Research Methodology

Figure 2 Research Process Flow Chart

Figure 3 Comparative Analysis, by Geography, 2016-2025 (Value %)

Figure 4 Regulatory Framework Analysis

Figure 5 Pharmaceutical Outsourcing Services Market, by Service, 2016 – 2027 (USD Billion)

Figure 6 Pharmaceutical Outsourcing Services Market, by Geography, 2016 – 2027 (USD Billion)

Additional Details

Publisher

AnalystView

Publisher Information

AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. Our company is led by a team of passionate, naturally curious, and strategic thinkers from different industry backgrounds.



These experts are dedicated to creating concrete market data analysis in various industries such as Healthcare, Bulk Chemicals, Semiconductors and Electronics, Foods and Beverages. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends.



We aim to be the number one choice for various clients who require credible data to make vital business decisions. We wish to be a trusted and reliable analytics partner to major business organizations.



We understand that critical business decisions can be taken only when verified, authentic information is available. Therefore, our experts work meticulously to provide our clients with the accurate data, so that they need not spend time in verifying it.



It is also our goal to help our clients ignore traditional research methods that require a large amount of capital, manpower, and most important of it all – the time. We know that these factors are precious to a company and always follow the latest research techniques that produce the required result in a short span of time.

Reference

270565 | AV177

Number of Pages

209

Report Format

PDF

AnalystView Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Sun Pharmaceutical 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Yabao Pharmaceutical Group Co., Ltd. (600351) - Financial and Strategic SWOT Analysis Review
SummaryYabao Pharmaceutical Group Co., Ltd. (Yabao Pharmaceutical) is a pharmaceutical company that ...
08 Nov 2015 by Global Data USD $300 More Info
Wuyi International Pharmaceutical Company Limited (1889) - Financial and Strategic SWOT Analysis Review
SummaryWuyi International Pharmaceutical Company Limited (Wuyi International) is a pharmaceutical co...
08 Nov 2015 by Global Data USD $300 More Info
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196) - Medical Equipment - Deals and Alliances Profile
SummaryShanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma) is a biopharmaceutical and hea...
23 Oct 2015 by Global Data USD $250 More Info
Otsuka Pharmaceutical Co., Ltd. - Medical Equipment - Deals and Alliances Profile
SummaryOtsuka Pharmaceutical Co., Ltd. (OPC) a subsidiary of Otsuka Holdings Co., Ltd. is a pharmace...
23 Oct 2015 by Global Data USD $250 More Info
Gulf Pharmaceutical Industries P.S.C. (JULPHAR) - Financial and Strategic SWOT Analysis Review
Gulf Pharmaceutical Industries P.S.C. (JULPHAR) - Financial and Strategic SWOT Analysis Review provi...
20 Oct 2015 by Global Data USD $125 More Info
Glide Pharmaceutical Technologies Limited - Medical Equipment - Deals and Alliances Profile
SummaryGlide Pharmaceutical Technologies Limited (Glide Pharma) is a specialty pharmaceutical develo...
16 Oct 2015 by Global Data USD $250 More Info
Collegium Pharmaceutical, Inc. (COLL) - Medical Equipment - Deals and Alliances Profile
SummaryCollegium Pharmaceutical, Inc. (Collegium) is a pharmaceutical company which develops proprie...
16 Oct 2015 by Global Data USD $250 More Info
Hisamitsu Pharmaceutical Co., Inc. (4530) - Medical Equipment - Deals and Alliances Profile
SummaryHisamitsu Pharmaceutical Co., Inc. (Hisamitsu Pharmaceutical) is a pharmaceutical company tha...
16 Oct 2015 by Global Data USD $250 More Info
Adapting to a New Environment: Emerging Segmentation Practice in the Pharmaceutical Industry
Introduction“If you’re not talking segmentation, then you’re not talking marketing.” While German-...
01 Feb 2012 by FirstWord Pharma USD $595 More Info

This report is published by AnalystView

AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. Our company is led by a team of passionate, naturally curious, and strategic thinkers from different industry backgrounds.

These experts are dedicated to creating concrete market data analysis in various industries such as Healthcare, Bulk Chemicals, Semiconductors and Electronics, Foods and Beverages. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends.

We aim to be the number one choice for various clients who require credible data to make vital business decisions. We wish to be a trusted and reliable analytics partner to major business organizations.

We understand that critical business decisions can be taken only when verified, authentic information is available. Therefore, our experts work meticulously to provide our clients with the accurate data, so that they need not spend time in verifying it.

It is also our goal to help our clients ignore traditional research methods that require a large amount of capital, manpower, and most important of it all – the time. We know that these factors are precious to a company and always follow the latest research techniques that produce the required result in a short span of time.

Download Free Report Summary PDF

Pharmaceutical Outsourcing Services Market, By Service (Product design, Product testing, Consulting, Auditing and Assessment, Regulatory Affairs, Product maintenance, and Training), and Geography (NA, EU, APAC, and RoW) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...